Shiroyama
Department of Respiratory Medicine
Japan
Shiroyama is currently affiliated to Department of Respiratory Medicine Osaka University Hospital continuing research in the specialized scientific area A98of Pneumology. Dr. Shiroyama is serving as an honorary reviewer for Nuclear Medicine & Radiation Therapy & other reputed journals and has authored several articles along with chapters in different books related to Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNA
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 